[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 0.43% 470.50 467.50 472.00 472.50 465.00 469.00 65,356 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 166.7 -138.8 -13.2 - 4,067

Hutchmed (china) Share Discussion Threads

Showing 3476 to 3500 of 3525 messages
Chat Pages: 141  140  139  138  137  136  135  134  133  132  131  130  Older
DateSubjectAuthorDiscuss
04/10/2021
12:17
Shaker There appears to be no business reason for the selling. It seems to be caught up with China issues in US, HK and internally. The company is now well funded and is nesting in its pipeline and infrastructure. There is a bit of a lull in NDAs and approvals, but that is going to change starting in April 2022 and judging by recent pipeline progressions there should be several new NDAs across late 2022-2024. Asian market closure days seem to be particularly bad for US markets as they go full risk off and drop 5%. Buy for 2025.
whatja
04/10/2021
11:15
Already overweight here but looking so cheap. Every time I look at adding, it sinks further. Bumpy ride here. Presumably some heavy selling for some reason?
shaker44
01/10/2021
07:44
I was hoping the Stock Connect program and inclusion in various indexes of Hong Kong-listed stocks, including the Hang Seng Healthcare Index and the Hang Seng Hong Kong-Listed Biotech Index would give us a boost. However, there are so many negatives for China at the moment. One big one is the forced rolling power cuts that will be enforced throughout the winter due to a shortage of natural gas and other factors. This will effect factories although whether drug manufacturing can get some kind of exemption is not clear.
nerdofsteel
29/9/2021
11:43
I also note that HCM are on the shortlist for one award in December here: Https://pharmaintelligence.informa.com/events/awards/scrip-awards-2021/shortlist Mentioned well into the video.
lauders
29/9/2021
11:27
A series of pretty good announcements recently and all we have seen is a drift. Pretty amazing. Thought the Chinese listing was going to energize HCM? Doesn't really seem to have maintained the initial spike on listing. Sure patience will be rewarded but this is one trying share price!
lauders
22/9/2021
17:03
HUTCHMED (NASDAQ:HCM) was downgraded by The Goldman Sachs Group from a "buy" rating to a "neutral" rating in a research report issued on Wednesday, The Fly reports. They presently have a $46.00 price target on the stock. The Goldman Sachs Group's target price would suggest a potential upside of 20.48% from the stock's previous close.
its the oxman
22/9/2021
15:47
Yet again there's no indication as to the reason for such a drop particularly when there's hopeful news on drug development and placing. ANNOYING!
fionascott1234
22/9/2021
15:29
Dear old Hutchmed might be the promised land but it often feels as if we're still wandering in the wilderness ;(
steeplejack
22/9/2021
15:20
Nasty fall today for some reason 538p?
its the oxman
18/9/2021
15:59
China Merchants Bank releasaed this comprehensive research note yesterday and are confident of revenues well in excess of $2bn by 2030 and free cashflow generation by 2025. Https://www.cmbi.com/article/5925.html?lang=cn Against peers a conservative P/S of 25 and P/E of 60 will give them a mcap of around $50bn by then, and I fully expect them to achieve it if the pipeline plays out as expected. If it doesn't or the competition beat them with certain candidates then maybe it will be less but revenues will be many many multiples of today's figures, and earnings should be well into positive territory. The only other issue to hamper the valuation accretion is potntial geo-political issues.
nerdofsteel
16/9/2021
14:47
My goodness this is bleeding daily now.
fionascott1234
15/9/2021
05:35
The most recent Bloomberg interview with CH: Https://www.bloomberg.com/news/videos/2021-09-10/hutchmed-ceo-on-china-s-biotech-sector-outlook-video?sref=zO7VMu8a
lauders
13/9/2021
07:38
Nice announcement re 689 being granted BTD in China. Ph2 registration trial started in April with ph1 data at ESMO now. Their work with the regulators in China and US appears to be strong.
whatja
12/9/2021
12:32
I agree, but 1st line setting rather than 2nd or 3rd so huge potential. As our CEO said recently "we expect by 2025 to have 9 therapies launched in China, we expect to have 5 launched outside of China. and we expect another 6 to be in registration studies outside China and 9 inside China. If we are able to deliver on these kinds of numbers HUTCHMED WILL BE A VERY BIG COMPANY BY 2025 AND I'M FULLY OF THE VIEW THAT WE'LL BE ABLE TO DELIVER THESE KIND OF NUMBERS"
nerdofsteel
08/9/2021
22:31
The commencement of two trials announced recently are potentially very exciting. Both are combos Sulanda + Beigene PD1 Orpathys + tagrisso in a first line setting Unfortunately we need to wait along time for the results, my guess is 2-3 years for NDA submissions. Keep holding.
whatja
08/9/2021
15:52
It's an AIM market share!
steeplejack
07/9/2021
15:42
Oh dear back to 570p, this is one frustrating share.
its the oxman
03/9/2021
16:31
Hoping we've done the China wobble and consolidation around 600p, ready for a big push higher.
its the oxman
01/9/2021
05:41
Up >6% in HK at present today. Hope we have a recovery of the recent weakness here and start the move to new highs. Would be nice.
lauders
26/8/2021
18:20
Stock connect should be very interesting - Chinese love fast growing Biotechs, and the symbol 13 is considered to be very lucky in China.
nerdofsteel
24/8/2021
14:27
Decent buying today along with good lifts in both Shanghai & Hang indices and yet,....
fionascott1234
23/8/2021
06:05
Today's announcement of the inclusion in various indexes including the Biotech, Healthcare and Composite is great news and should result in a flurry of institutional buyers. Even more important is the inclusion in the stock connect program and north and southbound trading opening the shares up to mainland chinese investors.
nerdofsteel
23/8/2021
03:28
Being received quite well in HK at present (+3.5%): Https://www.hutch-med.com/hutchmed-selected-as-constituent-of-certain-hang-seng-indexes/ Hong Kong, Shanghai & Florham Park, NJ — Monday, August 23, 2021: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that HUTCHMED has been selected as a constituent stock of several indexes administered by Hang Seng Indexes Company Limited (“Hang Seng”), including the Hang Seng Composite Index, in accordance with the latest index series release by Hang Seng, with effect from Monday, September 6, 2021.
lauders
20/8/2021
11:14
Yup. I've got a small stake in Tencent as well 😕.
nahoon
20/8/2021
09:51
The likes of Alibaba have halved in the year and are now back to levels not seen since Aug 2019.There is little sign of the Chinese authorities loosening their administrative grip in the field of retail,tech and finance.Some fund managers regard the fall in the Chinese exchanges as a buying opportunity but others have sold out not being prepared to guess the likely machinations of the Chinese political masters.Long term its probably right to maintain a Chinese weighting in a global portfolio but its very irritating to see the slump in stock prices purely due to political interference whether that interference is justified or not.I feel that the fall back in HCM is almost entirely due to shifts of global capital out of Chinese exchanges and its difficult to see confidence returning soon.There's a health warning attached to buying all chinese related securities just now.
steeplejack
Chat Pages: 141  140  139  138  137  136  135  134  133  132  131  130  Older
ADVFN Advertorial
Your Recent History
LSE
HCM
Hutchmed (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211025 02:24:20